State-of-the-Art cGMP Sterile Drug Product Manufacturing Facilities

Facility Capabilities

ForDoz Pharma operates a cGMP pharmaceutical manufacturing facility exclusively dedicated to the development and commercial production of sterile injectable drug products.

Designed to support both conventional and complex sterile formulations, our entire site operations combine advanced manufacturing infrastructure, analytical sciences, microbiological support, quality systems, and regulatory oversight within a single U.S.-based facility.

Manufacturing & Technical Capabilities
  • Aseptic processing and sterile fill-finish operations
  • Conventional aqueous sterile formulations
  • Lyophilized sterile products
  • Liposomal and nanoparticle-based drug delivery systems
  • Microsphere and polymer-based controlled release formulations
  • Long-acting injectable (LAI) therapies
  • High-potency sterile compounds
  • Integrated isolator-based manufacturing technologies
  • Process development and clinical scale-up
  • Commercial manufacturing operations
Integrated Facility Infrastructure

ForDoz Pharma maintains a fully integrated pharmaceutical manufacturing environment supported by:

  • State-of-the-art cleanroom manufacturing suites with isolator technology
  • warehousing and material management operations
  • Autoclave and vaporized hydrogen peroxide (VHP) sterilization systems
  • Glass cleaning and component preparation equipment
  • Research & development and process development laboratories
  • Quality control analytical laboratories
  • Microbiology and environmental monitoring laboratories
Quality & Compliance

Quality is embedded throughout every aspect of our operation. Our teams operate within a robust cGMP environment designed to ensure product safety, regulatory compliance, and operational reliability across clinical and commercial manufacturing activities.

With extensive experience supporting regulatory submissions, inspections, and commercial manufacturing operations, ForDoz Pharma remains committed to maintaining the highest standards of pharmaceutical quality and scientific excellence.

Future Expansion

As part of our long-term manufacturing strategy, ForDoz Pharma continues to invest and expand our sterile manufacturing capacity to support future projects involving manufacturing sterile injectable therapies in the United States.